Enbridge Inc vs Twist Bioscience Corp — how do they compare? Enbridge Inc trades at $51.67 (market cap $112.62B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Enbridge Inc is far larger — about 14.6× Twist Bioscience Corp's market cap, and Enbridge Inc pays a 5.34% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| ENB | TWST | |
|---|---|---|
Market Cap | $112.62B | $7.72B |
Sector | Energy | Health |
52-Week High | $58.04 | $124.88 |
52-Week Low | $45.23 | $24.16 |
Enterprise Value | $196.53B | $7.65B |
Dividend Yield | 5.34% | — |
Trailing returns across standard periods
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →